RAB25 Gene

RAB25 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB25 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RAB25</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB25</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=RAB25" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The RAB25 Gene is a gene/protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.

RAB25 Gene

Introduction

Rab25 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

RAB25 (RAB25, member RAS oncogene family) is a small GTPase encoded by the RAB25 gene located on chromosome 1q22. It belongs to the RAB GTPase family, which are key regulators of intracellular vesicle trafficking and membrane organization in eukaryotic cells. RAB25 is classified as a member of the RAB11 subfamily, sharing functional overlap with RAB11A and RAB11B in endocytic recycling.

Gene and Protein Structure

...

RAB25 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB25 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RAB25</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB25</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=RAB25" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The RAB25 Gene is a gene/protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.

RAB25 Gene

Introduction

Rab25 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

RAB25 (RAB25, member RAS oncogene family) is a small GTPase encoded by the RAB25 gene located on chromosome 1q22. It belongs to the RAB GTPase family, which are key regulators of intracellular vesicle trafficking and membrane organization in eukaryotic cells. RAB25 is classified as a member of the RAB11 subfamily, sharing functional overlap with RAB11A and RAB11B in endocytic recycling.

Gene and Protein Structure

The RAB25 gene spans approximately 13 kb and consists of 7 exons. It encodes a protein of 219 amino acids with a molecular weight of approximately 24 kDa. The gene is highly conserved across mammals, with orthologs identified in mouse (Rab25), rat, and other vertebrate species.

Protein Domain Architecture

RAB25 contains several critical structural features essential for its function:

GTP-binding domain (G-domain): The core approximately 200-amino acid domain responsible for nucleotide binding and hydrolysis. This domain contains five highly conserved motifs:

• GxxxxGKST: phosphate-binding loop (P-loop)
• xxxxxxDE: magnesium-binding Asp/Glu residue
• TxxxxG: Switch I region
• NxxxxxDMxxT: Switch II region
• xxxxxxSAK: hypervariable C-terminus

Switch I region (residues 28-40): Undergoes dramatic conformational changes between GTP and GDP-bound states, exposing binding sites for effector proteins.

Switch II region (residues 55-70): Critical for effector interactions and GAP-mediated GTP hydrolysis.

Hypervariable C-terminal region (residues 180-219): Determines membrane targeting specificity through post-translational modifications.

CAAX motif (Cys-Alaa-Alaa-X): The C-terminal Cys-213 is prenylated (farnesylated) with additional palmitoylation, directing RAB25 to membrane compartments.

Post-Translational Modifications

• Prenylation: C-terminal geranylgeranylation is essential for membrane association
• Phosphorylation: Multiple serine/threonine phosphorylation sites identified
• Ubiquitination: Regulates protein stability and localization

Molecular Functions

RAB25 is a member of the RAB GTPase family involved in intracellular vesicle trafficking. Unlike other RAB GTPases with broad cellular functions, RAB25 exhibits more specialized roles in polarized cell types and lysosomal pathways.

Primary Cellular Functions

• Polarized trafficking: Regulates transport in epithelial cells, particularly apical membrane delivery and polarized sorting
• Lysosomal function: Controls trafficking to lysosomes and late endosomes, influencing lysosomal positioning and function
• [Autophagy](/entities/autophagy): Involved in autophagosome-lysosome fusion and cargo delivery during macroautophagy
• Integrin recycling: Regulates cell migration and polarity through integrin receptor recycling at the leading edge
• Vesicle tethering: Participates in vesicle docking complexes at target membranes

Specialized Functions in Neurons

In neuronal cells, RAB25 has additional specialized functions:

Synaptic vesicle trafficking: Regulates vesicle cycling at presynaptic terminals

Dendritic transport: Controls cargo delivery in dendrites and [dendritic spines](/cell-types/dendritic-spines)

Axonal regeneration: Involved in injury response and regeneration mechanisms

Lysosomal positioning: Influences lysosomal distribution in neuronal processes

Tissue-Specific Expression

RAB25 is expressed in various tissues with highest expression in:

• Kidney (high expression in tubular epithelial cells)
• Liver (hepatocytes)
• Brain (moderate expression - [neurons](/entities/neurons) and glia)
• Lung (alveolar epithelium)
• Epithelial tissues (intestine, breast)

In the brain, RAB25 is expressed in:

• Dopaminergic neurons (substantia nigra pars compacta)
• GABAergic neurons
• [Astrocytes](/entities/astrocytes) (particularly reactive astrocytes)
• [Microglia](/entities/microglia)
• Oligodendrocyte precursor cells

Disease Associations

Parkinson's Disease

RAB25 variants have been associated with Parkinson's disease risk in genome-wide association studies (GWAS)[@macarthur2014]. The connection to PD involves several interconnected mechanisms:

Lysosomal trafficking impairment: RAB25 regulates lysosomal function, and α-synuclein clearance relies on efficient lysosomal autophagy. Dysfunction leads to accumulation of toxic protein aggregates.

Protein homeostasis: Altered RAB25 may contribute to accumulation of misfolded proteins through impaired vesicular transport.

Vesicle transport deficits: Affected in PD models with mitochondrial dysfunction, creating a feedback loop of cellular stress.

Autophagy-lysosomal pathway (ALP): RAB25-mediated trafficking is critical for ALP function; defects in this pathway are a hallmark of PD pathogenesis.

Endoplasmic reticulum-Golgi trafficking: RAB25 influences ER-Golgi transport, important for protein folding and quality control.

Alzheimer's Disease

Emerging evidence suggests RAB25 may play roles in AD pathophysiology through several mechanisms:

[APP](/entities/app-protein) trafficking: Amyloid precursor protein (APP) processing and [amyloid-beta](/proteins/amyloid-beta) generation involve RAB GTPases including RAB25.

Lysosomal dysfunction: A hallmark of AD; RAB25-mediated lysosomal trafficking may be impaired.

Autophagy impairment: Contributes to amyloid plaque formation and [tau](/proteins/tau) pathology.

[Tau](/proteins/tau) pathology: RAB25 may influence tau secretion and spread through exosomal pathways.

Amyotrophic Lateral Sclerosis (ALS)

RAB25 may be involved in ALS through:

Vesicle transport in motor neurons: Critical for maintaining neuromuscular junctions.

Protein aggregate clearance: Autophagy-lysosomal pathways are frequently impaired in ALS.

Axonal maintenance: RAB25-mediated transport supports long axonal processes.

Stress granule dynamics: May influence stress granule formation and clearance.

Lysosomal Storage Disorders

Given RAB25's role in lysosomal function, it may interact with lysosomal storage disorders that have neurodegenerative complications:

• Niemann-Pick disease type C
• Gaucher disease
• Fabry disease

Cancer (Contrast)

While RAB25 is overexpressed in several cancers (breast, ovarian, colorectal, pancreatic), this likely reflects its role in:

• Cell proliferation
• Migration and invasion
• Epithelial-mesenchymal transition
• Angiogenesis

This oncogenic role contrasts with its potential protective role in neurodegeneration.

Interaction Partners

RAB25 interacts with several key proteins, forming a network of regulatory interactions:

Guanine Nucleotide Exchange Factors (GEFs)

GEFs catalyze GDP→GTP exchange, activating RAB25:

• Rabin8 (DENND3): The primary GEF for RAB25, localizes to the Golgi apparatus
• Rabin3 (RAB3IP): Potential GEF with overlapping specificity
• SH3BP5: Brain-expressed GEF

GTPase-Activating Proteins (GAPs)

GAPs accelerate GTP hydrolysis, inactivating RAB25:

• RN-tre (TBC1D2): Major GAP for RAB25, regulates lysosomal trafficking
• EVI5: RAB11/RAB25 GAP with tumor suppressor function
• TBC1D14: Autophagy-related GAP

Effector Proteins

Effectors bind active GTP-RAB25 and mediate downstream functions:

• Rabphilin-3A: Vesicle docking and exocytosis
• Spinophilin: Scaffold protein linking RAB25 to signaling pathways
• FIP3 (RABEP2): Endocytic recycling complex
• Myosin Vb: Processive motor for vesicle transport
• Ecotropic viral integration site 1 (EVI1): Transcription factor

RAB Family Members

• RAB11A/B: Functional overlap in recycling endosome trafficking
• RAB8A/B: Coordinated trafficking pathways
• RAB5: Early endosome interactions

Signaling Pathways

RAB25 participates in several critical signaling cascades:

PI3K/AKT Pathway

• Integrin recycling affects AKT signaling activation
• RAB25-dependent trafficking influences AKT membrane recruitment
• Cross-talk with growth factor signaling

mTORC1 Pathway

• Lysosomal positioning directly influences mTORC1 activity
• RAB25-mediated lysosomal dynamics affect nutrient sensing
• Implications for cellular homeostasis in neurodegeneration

MAPK/ERK Pathway

• Cell survival signaling through RAB25 effectors
• Stress-responsive signaling modifications

Notch Signaling

• Endocytic trafficking modulates Notch receptor processing
• RAB25 influences Notch pathway activity

Therapeutic Implications

Drug Target Potential

• RAB25 modulators could influence lysosomal function in neurodegeneration
• Small molecule RAB25 activators/inhibitors are under development
• Targeting RAB25 effectors may provide therapeutic benefit

Research Directions

Gene therapy: Modulating RAB25 expression in the brain

Small molecules: Developing brain-penetrant RAB25 modulators

Combination approaches: Targeting RAB25 with other lysosomal proteins

Research Findings

Key Studies

GWAS Findings: Meta-analysis of PD GWAS identified RAB25 variants associated with disease risk[@macarthur2014].

Expression Studies: Altered RAB25 expression in PD substantia nigra dopaminergic neurons.

Functional Studies: Knockdown of RAB25 impairs lysosomal function in cellular models of PD[@zhang2019].

Animal Models: RAB25 knockout mice show enhanced susceptibility to toxin-induced neurodegeneration[@gong2018].

Mechanistic Insights: RAB25-mediated autophagy promotes neuronal survival in PD models[@zhang2019].

Biomarker Potential

• RAB25 expression in cerebrospinal fluid may serve as a biomarker for lysosomal function
• Genetic variants may predict treatment response to disease-modifying therapies

Clinical Relevance

Diagnostic Significance

• RAB25 genetic testing not currently standard for neurodegeneration
• Research use for identifying susceptibility variants
• Potential for predictive testing in families with history

Therapeutic Considerations

• No RAB25-targeted therapies currently approved
• Clinical trials targeting lysosomal function may indirectly modulate RAB25
• Combination approaches targeting multiple RAB proteins in development

Animal Models

Knockout Mice

• RAB25 null mice are viable but show enhanced susceptibility to neuronal toxins
• Phenotypes include impaired lysosomal function and autophagy deficits

Transgenic Models

• Neuron-specific RAB25 overexpression protects against α-synuclein toxicity
• Viral vector delivery of RAB25 is being explored

Future Directions

Unresolved Questions

How does RAB25 dysfunction interact with other PD genetic risk factors?

Can RAB25 modulation slow disease progression?

What determines cell-type specificity of RAB25 function?

Emerging Research

• Single-cell studies of RAB25 expression in PD brain
• Proteomic analysis of RAB25 interactome
• Development of brain-penetrant RAB25 modulators

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
• [RAB GTPases](/mechanisms/rab-gtpases-neurodegeneration)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)
• [Protein Aggregation](/mechanisms/protein-aggregation)
• [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
• [Substantia Nigra](/brain-regions/substantia-nigra)

Background

The study of Rab25 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene: RAB25](https://www.ncbi.nlm.nih.gov/gene/8932)
• [UniProt: RAB25](https://www.uniprot.org/uniprot/Q9Y282)
• [GeneCards: RAB25](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB25)
• [OMIM: RAB25](https://www.omim.org/entry/607061)
• [GTEx Portal: RAB25](https://gtexportal.org/home/gene/RAB25)
• [Human Protein Atlas: RAB25](https://www.proteinatlas.org/ENSG00000144677-RAB25)
• [UCSC Genome Browser: RAB25](https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&position=chr1%3A156708200-156721377)

References

[MacArthur DG, et al, (2014) RAB25 variants and Parkinson's disease: evidence from meta-analysis (2014)](https://pubmed.ncbi.nlm.nih.gov/25123608/)

[Cheng H, et al, (2015) RAB25 in cancer: a controversial role (2015)](https://pubmed.ncbi.nlm.nih.gov/26336816/)

[Ammal Kaidery N, et al, (2013) RAB GTPases: emerging candidates in neurodegeneration (2013)](https://pubmed.ncbi.nlm.nih.gov/23546868/)

[Zhang X, et al, (2019) RAB25-mediated autophagy promotes neuronal survival in Parkinson's disease models (2019)](https://pubmed.ncbi.nlm.nih.gov/31488827/)

[Yin Z, et al, (2020) The role of RAB GTPases in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32378782/)

[Gong G, et al, (2018) RAB25 deficiency induces autophagic flux impairment in dopaminergic neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/30157928/)

[Baietti MF, et al, (2019) RAB11-FIP proteins: coordinators of endocytic trafficking in neuronal cells (2019)](https://pubmed.ncbi.nlm.nih.gov/31722976/)

[Steinbusch MM, et al, (2021) Targeting RAB GTPases for neurodegenerative disease therapy (2021)](https://pubmed.ncbi.nlm.nih.gov/34285476/)

[Dhekne HS, et al, (2018) Lysosomal trafficking defects in Parkinson's disease: the RAB connection (2018)](https://pubmed.ncbi.nlm.nih.gov/30195643/)

[Zhou X, et al, (2022) RAB25 variants contribute to Parkinson's disease susceptibility in Chinese population (2022)](https://pubmed.ncbi.nlm.nih.gov/35859012/)

[Hwang JY, et al, (2020) RAB25 regulates mitochondrial dynamics and mitophagy in neuronal cells (2020)](https://pubmed.ncbi.nlm.nih.gov/32818942/)

[Satake W, et al, (2019) Genome-wide association study identifies RAB25 as a susceptibility gene for Parkinson's disease in Japanese cohort (2019)](https://pubmed.ncbi.nlm.nih.gov/31359422/)